Literature DB >> 18845435

Interaction of kendomycin and semi-synthetic analogues with the anti-apoptotic protein Bcl-xl.

Christian O Janssen1, Stephanie Lim, Ee Peng Lo, Kah Fei Wan, Victor C Yu, May Ann Lee, Siew Bee Ng, Martin J Everett, Antony D Buss, David P Lane, Rustum S Boyce.   

Abstract

The cytotoxic macrolide kendomycin was identified as a ligand of Bcl-xl, an anti-apoptotic member of the Bcl-2 protein family. Hydrolysis-stable and protonable semi-synthetic analogues have been obtained that retain cytotoxicity and Bcl-xl binding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845435     DOI: 10.1016/j.bmcl.2008.09.071

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  The 160K Natural Organism Library, a unique resource for natural products research.

Authors:  Siew Bee Ng; Yoganathan Kanagasundaram; Hao Fan; Prakash Arumugam; Birgit Eisenhaber; Frank Eisenhaber
Journal:  Nat Biotechnol       Date:  2018-07-06       Impact factor: 54.908

Review 2.  Strategies for construction of the all-carbon macrocyclic skeleton of the ansamycin antibiotic-kendomycin.

Authors:  Shu Xu; Hirokazu Arimoto
Journal:  J Antibiot (Tokyo)       Date:  2016-02-10       Impact factor: 2.649

3.  Enrichment of druggable conformations from apo protein structures using cosolvent-accelerated molecular dynamics.

Authors:  Andrew Kalenkiewicz; Barry J Grant; Chao-Yie Yang
Journal:  Biology (Basel)       Date:  2015-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.